Pacira BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.About PCRX
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.
CEOFrank D. Lee
CEOFrank D. Lee
Employees790
Employees790
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2006
Founded2006
Employees790
Employees790
PCRX Key Statistics
Market cap1.16B
Market cap1.16B
Price-Earnings ratio58.93
Price-Earnings ratio58.93
Dividend yield—
Dividend yield—
Average volume810.69K
Average volume810.69K
High today$26.46
High today$26.46
Low today$25.17
Low today$25.17
Open price$25.89
Open price$25.89
Volume770.80K
Volume770.80K
52 Week high$27.64
52 Week high$27.64
52 Week low$18.17
52 Week low$18.17
Stock Snapshot
With a market cap of 1.16B, Pacira BioSciences(PCRX) trades at $26.29. The stock has a price-to-earnings ratio of 58.93.
On 2025-12-14, Pacira BioSciences(PCRX) stock moved within a range of $25.17 to $26.46. With shares now at $26.29, the stock is trading +4.5% above its intraday low and -0.6% below the session's peak.
Trading volume for Pacira BioSciences(PCRX) stock has reached 770.8K, versus its average volume of 810.69K.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
28.6%
Sell
14.3%
People also own
Based on the portfolios of people who own PCRX. This list is generated using Robinhood data, and it’s not a recommendation.